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Mitochondria are highly efficient energy-transforming organelles that convert energy
stored in nutrients into ATP. The production of ATP by mitochondria is dependent on
oxidation of nutrients and coupling of exergonic electron transfer reactions to the genesis
of transmembrane electrochemical potential of protons. Electrons can also prematurely
“spin-off” from prosthetic groups in Krebs cycle enzymes and respiratory complexes
and univalently reduce di-oxygen to generate reactive oxygen species (ROS) superoxide
(O2•−) and hydrogen peroxide (H2O2), important signaling molecules that can be toxic at
high concentrations. Production of ATP and ROS are intimately linked by the respiratory
chain and the genesis of one or the other inherently depends on the metabolic state
of mitochondria. Various control mechanisms converge on mitochondria to adjust ATP
and ROS output in response to changing cellular demands. One control mechanism that
has gained a high amount of attention recently is S-glutathionylation, a redox sensitive
covalent modification that involves formation of a disulfide bridge between glutathione
and an available protein cysteine thiol. A number of S-glutathionylation targets have
been identified in mitochondria. It has also been established that S-glutathionylation
reactions in mitochondria are mediated by the thiol oxidoreductase glutaredoxin-2 (Grx2).
In the following review, emerging knowledge on S-glutathionylation reactions and its
importance in modulating mitochondrial ATP and ROS production will be discussed. Major
focus will be placed on Complex I of the respiratory chain since (1) it is a target for
reversible S-glutathionylation by Grx2 and (2) deregulation of Complex I S-glutathionylation
is associated with development of various disease states particularly heart disease. Other
mitochondrial enzymes and how their S-glutathionylation profile is affected in different
disease states will also be discussed.
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INTRODUCTION
The degree of biological complexity is inherently related to energy
flux (Lane and Martin, 2010; Wallace, 2010). In aerobic eukary-
otes most energy transfer reactions take place in mitochondria,
double membrane organelles that transform energy stored in
nutrients into ATP. Energy conversion in mitochondria involves
coupling exergonic electron transfer reactions to the production
of ATP, an indispensable form of energy required to perform
work in the cell. Aerobic respiration starts when electrons are
stripped from nutrients via the concerted action of eight dif-
ferent Krebs cycle enzymes which results in the production of
the electron carriers NADH and succinic acid (Figure 1) (Brand
and Nicholls, 2011; Mailloux and Harper, 2012; Verkhovskaya
and Bloch, 2013). Electrons from NADH and succinic acid are
then transferred to respiratory Complex I (NADH:ubiquinone
oxidoreductase) and Complex II (Succinate dehydrogenase; Sdh)
and then systematically passed through a series of prosthetic
groups to ubiquinone forming ubiquinol. Other enzymes includ-
ing electron transfer flavoprotein oxidoreductase (ETF-QO),
dihydroorotate dehydrogenase, FAD-linked glycerol-3-phosphate
dehydrogenase, proline dehydrogenase, and sulfide:quinone oxi-
doreductase (SQR) also donate electrons from their cognate
substrates to ubiquinone (Mailloux et al., 2013a; Quinlan et al.,
2014). The electrons are then passed through prosthetic groups
in respiratory Complex III (Ubiquinol:cytochrome C oxidore-
ductase) and Complex IV (Cytochrome C oxidase; COX) to O2
(Figure 1). Electron transfer through the Complexes fromNADH
to O2 is energetically favorable which is coupled to the pump-
ing of protons into the intermembrane space (IMS) from the
matrix (matrix) generating a protonmotive force (pmf) which
is tapped by Complex V (ATP synthase) for ATP synthesis
(Walker, 2013).
Bacteria also harbor enzymes and protein complexes that cou-
ple nutrient metabolism to the reduction of O2 and production
of ATP. Thus, it is important to consider why mitochondria are
responsible for the evolution of more complex life and why bio-
logical complexity is out of the humble bacterium’s grasp. The
efficiency of aerobic metabolism in bacteria depends on the ratio
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FIGURE 1 | Production of ATP and ROS by the electron transport
chain. Nutrients in the form of glucose, fatty acids, or amino acids are
converted into the Krebs cycle intermediates and then oxidized by 8
different enzymes. During carbon oxidation electrons are extracted and
ferried through the respiratory complexes to drive ATP production
(OXPHOS). Electrons from the Krebs cycle enter the respiratory chain via
NADH at Complex I or succinate at Complex II. Electron flow to the
terminal acceptor di-oxygen which creates the transmembrane
electrochemical potential of protons which drives ATP production by
Complex V. Red circles: represent major sites for ROS production in
mitochondria (Univalent reduction of di-oxygen (O2) to H2O. The standard
redox potentials for each univalent reduction of O2, O2•−, H2O2, and
OH•. are indicated in the diagram). Pdh; pyruvate dehydrogenase, Odh;
2-oxoglutarate dehydrogenase, I, Complex I; II, Complex II; III, Complex
III; IV, Complex IV; V, Complex V; ANT, adenine nucleotide translocase;
VDAC, voltage-dependent anion channel.
of membrane surface area to cell volume (Lane and Martin,
2010; Lane, 2014). As the size of a microbe increases there is a
hyperbolic decrease in respiratory and nutrient absorption effi-
ciency (Lane, 2005, 2014). Mitochondria overcome surface area
restraints with a highly folded selectively permeable and energy
transducing mitochondrial inner membrane (MIM). The inward
folding of the MIM creates deep invaginations called cristae
enriched in respiratory complexes and Krebs cycle enzymes
which amplifies energy transduction. The mitochondrial MIM
is ∼5–7 nm thick and can generate a transmembrane electro-
chemical proton potential of ∼150–180mV (Perkins et al., 1997;
Gerencser et al., 2012). Thus, the voltage gradient experienced
by the MIM in respiring mitochondria is ∼300, 000V cm−1.
In addition, mammalian cells contain a number of mitochon-
dria which can occupy ∼2–40% of the cell volume (Brand,
2014). Based on this it is easy to see why a mitochondrion
can conserve far more energy from nutrient oxidation than a
microbe.
Mitochondria are highly dynamic organelles that are required
to furnish human tissues with ATP. Different tissues have different
energy demands which will dictate the number of mitochon-
dria within the tissue as well as its structure, size, density, and
ATP output. Various control mechanisms converge on mitochon-
dria to regulate nutrient uptake, ATP output, and ROS produc-
tion/degradation which is dependent on the energy demands
of the tissue. Coarse control mechanisms including mitochon-
drial fission and fusion, changes in cristae structure, respirasome
assembly, protein complex assembly, protein degradation and
expression of nuclear and mitochondrial genes play intricate roles
inmodulating ATP output bymitochondria. Rapid control mech-
anisms include allosteric interactions and covalent modifications.
Deregulation of mitochondrial control mechanisms have been
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associated with a number of pathologies including heart dis-
ease, neurological disorders, obesity, diabetes mellitus, and non-
alcoholic fatty liver disorder (Mailloux andHarper, 2011). Protein
thiol oxidation reactions, in particular S-glutathionylation, have
also been found to play a crucial role in modulating mitochon-
drial physiology, structure, and bioenergetics (Hurd et al., 2005;
Mailloux et al., 2013b; Drose et al., 2014). Here, we will survey
the importance of S-glutathionylation reactions in the control
of mitochondrial metabolism. Special emphasis will be given to
Grx2 and the control of Complex I activity and function and
how deregulation of S-glutathionylation cascades can lead to
development of disease.
MITOCHONDRIAL OXYRADICAL HOMEOSTASIS
Di-oxygen has two unpaired electrons in its anti-bonding orbitals
with parallel spins and can accept only one electron at a time.
Thus, reduction of O2 to H2O can result in the formation of
oxyradical intermediates, specifically superoxide (O2•−), hydro-
gen peroxide (H2O2), and hydroxyl radical (OH•.) (Figure 1)
(Imlay, 2013). Superoxide is a membrane impermeant weak oxi-
dant and reductant and reacts with very few biological molecules
(Imlay, 2003). An important exception are iron-sulfur clusters
(Fe-S) which are in high abundance in mitochondria (Chepelev
and Willmore, 2011; James et al., 2012). O2•− reactivity and
diffusion capacity can be increased if it can be protonated to
form its conjugated acid, perhydroxyl radical (HO2•−) (De Grey,
2002). Since protonation/deprotonation equilibrium of O2•− has
a pKa of ∼4.88 most of the O2•− will exist in the deproto-
nated state (∼0.3% of O2•− exists as HO2•− ) (De Grey, 2002).
Hydrogen peroxide is a strong two electron oxidant but also
reacts with few biological molecules due to activation energy
restraints (Winterbourn, 2013). Importantly, H2O2 is able to dif-
fuse through membranes via aquaporins and reacts strongly with
seleno groups and protein cysteine thiols (-SH) which forms
the basis of antioxidant defense and redox signaling (Finkel,
2011; Mailloux et al., 2013a). Hydroxyl radical is by far the
most reactive molecule in the group and is able to oxidize a
number of different biological macromolecules. Hydroxyl rad-
ical has a redox potential of ∼2V and its reactivity is lim-
ited by diffusion (Imlay, 2013). The concentration of different
ROS species in a cell ranges from H2O2 > O2•− > OH•. with
H2O2 being found in the sub-μM range (10−7–10−9 M) and
O2•− in the low to mid pM range (Murphy, 2009; Sies, 2014).
Concentrations of OH. are much more difficult to estimate
given its rapid reaction kinetics (∼109 M−1 s−1) (Samuni et al.,
2002).
H2O2 and to a lesser extent O2•− play intricate roles in mito-
chondrial signaling to the rest of the cell. However, in large
quantities O2•− and H2O2 can be harmful. Overproduction
of O2•− can lead to the indiscriminant disassembly of Fe-S
clusters, in particular in aconitase (Acn) and sometimes Sdh,
Fumarase (Fum), and Complex I (James et al., 2012). Superoxide
can also combine with nitric oxide to generate peroxynitrite
(ONOO−) which rapidly oxidizes biological macromolecules
(Beckman and Koppenol, 1996). Overproduction of mitochon-
drial O2•− and the disassembly of Fe-S clusters can disable nutri-
ent oxidation and ATP production which has been implicated
in the pathogenesis of non-alcoholic fatty liver disease, obesity,
diabetes mellitus, and several neurological disorders (James et al.,
2012). Hydrogen peroxide can non-selectively oxidize protein
amino acids in particular cysteine and methionine rendering
proteins inactive and/or amenable to electrophilic modifica-
tion (Kaspar et al., 2009). Hydrogen peroxide can also par-
ticipate in Haber-Weiss reactions with O2•− to produce OH.
(Khan and Kasha, 1994). Over production of either O2•− and
H2O2 has been associated with mitochondrial DNA, protein,
and lipid damage, metabolic dysfunction and oxidative stress
(Berlett and Stadtman, 1997). In addition, over production of
ROS due to mitochondrial dysfunction has been linked to a
number of different pathologies including neurological diseases,
heart disease, obesity, and diabetes mellitus. ROS species are
dangerous but indispensable to mitochondrial function and sig-
naling. Thus, it is crucial for mitochondria to strike a balance
between ROS production and degradation which requires var-
ious antioxidant systems and mechanisms that control ROS
production.
Mitochondria can be a major source of reactive oxygen species
(ROS) in the aerobic cell (Brown and Borutaite, 2012). It is
estimated that ∼0.2–0.5% of the O2 consumed by mitochon-
dria is converted to ROS (Chance et al., 1979) however; the
actual amount of ROS generated by mitochondria depends on
its metabolic poise, redox state, O2 saturation, and concen-
tration of the redox active enzyme that can generate ROS.
Accessibility of an enzymatic ROS-generating site to di-oxygen
is also a key determinant for rate of ROS production (Klinman,
2007). Superoxide is the proximal ROS species generated by
mitochondria and can be produced by a number of differ-
ent enzymes and respiratory complexes in the Krebs cycle and
ETC (Figure 1) (Mailloux et al., 2013a). Complex I and III
are most often, if always, viewed as the major sites for O2•−
production. While the former generates O2•− on the matrix
side of the mitochondria only the latter can generate O2•− on
either intermembrane space side or matrix side of the MIM
(Turrens and Boveris, 1980). Experiments utilizing different
substrates and inhibitors have established that flavin mononu-
cleotide (FMN) prosthetic group is the major site for O2•−
genesis by Complex I (Kudin et al., 2004; Lambert and Brand,
2004). Another potential site for O2•− production by Complex
I is the Q-binding site which exhibits high sensitivity to pH
(Treberg et al., 2011). By utilizing different substrate combina-
tions and inhibitors like Antimycin A, stigmatellin, myxothia-
zol, and a Rieske Fe-S knockout model, it was established that
the Qo site of Complex III can also generate large amounts
of O2•− (Brunelle et al., 2005; Miwa and Brand, 2005). In
addition, Complex III releases most of its O2•− into the inter-
membrane space where it can participate in redox signaling
however; this may only occur under certain circumstances such
as hypoxia (Guzy et al., 2005). Note that mitochondrial ROS pro-
duction measurements are usually conducted at ambient oxygen
([O2]atmosphere ∼200μM at 37◦C) and in normal physiological
conditions the concentration of di-oxygen experienced by mito-
chondria is∼3–30μM (Turrens, 2003). However, considering the
low concentration of O2•− in mitochondria and standard reduc-
tion potential of O2•− (−0.160V, pH 7.0), its production will
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always be favorable even if [O2] were as low as 1μM (Murphy,
2009).
Since Complex I and III are often heralded as the chief
sites of mitochondrial ROS production, other sites including 2-
oxoglutarate dehydrogenase (Odh), branched chain amino acid
dehydrogenase (Bckdh), pyruvate dehydrogenase (Pdh), Sdh,
dihydroorotate dehydrogenase, FAD-linked glycerol-3-phosphate
dehydrogenase, proline dehydrogenase, and electron transfer
flavoprotein ubiquinone:oxidoreductase are often overlooked
(Murphy, 2012a). Intriguingly, recent reports have actually shown
that depending on which substrate is being metabolized, the
redox state of NADH/NAD, and whether or not electron trans-
fer inhibitors are present, the chief site of mitochondrial ROS can
vary drastically from one enzyme to the next. Blockage of the ETC
or high substrate concentration can induce an increase in ROS
production by Complex I and III. For instance, succinate at a final
concentration of 5mM can induce a substantial increase in O2•−
production from the FMN site of Complex I (Pryde and Hirst,
2011). Considering that the physiological concentration of suc-
cinate is in the μM range it does not seem that reverse electron
transfer from Complex II to Complex I is a significant phys-
iological source of mitochondrial ROS (Mailloux and Harper,
2011). In addition, pyruvate and malate/glutatamate, which gen-
erate Complex I substrate NADH, produce very little O2•− when
added to reaction chambers (Muller et al., 2008). The amount of
O2•− produced by pyruvate and malate/glutamate metabolism
can be amplified by rotenone, a Complex I inhibitor (Muller
et al., 2008). What is important to note here is that addition of
rotenone increases the amount of NADH which can induce a
substantial increase in O2•−/H2O2 production by Odh and Pdh
(Starkov et al., 2004; Fisher-Wellman et al., 2013). In one par-
ticular study, Quinlan et al. provided conclusive evidence that
Odh and Pdh, rather than the Complexes, serve as the major
sites for O2•−/H2O2 production in mitochondria (Quinlan et al.,
2014). In addition the authors contend that based on their results
mitochondrial O2•−/H2O2 production can be mistakenly associ-
ated with Complex I rather than Odh and Pdh (Quinlan et al.,
2014). Both Odh and Pdh are composed of three enzymes;
2-oxoglutarate or pyruvate dehydrogenase (E1), dihydrolipoyl
succinyltransferase or dihydrolipoyl acetyltransferase (E2), and
dihydrolipoyl dehydrogenase (E3) (McLain et al., 2011). The E2
subunit contains a lipoic acid residue which is extremely impor-
tant for catalysis of substrate oxidation and decarboxylation but is
also highly amenable to redox modifications. The E3 subunit har-
bors an FAD group which can readily participate in O2•−/H2O2
especially if NADH is high (Ambrus et al., 2009). It has been
known for some time that flavins can generate O2•−/H2O2 in
O2 saturated aqueous solutions and that Odh and Pdh can gen-
erate ROS (Starkov et al., 2004). However, the recent work by
Quinlan et al. really brings into question whether or not Complex
I or Odh and to a lesser extent Pdh are the major ROS produc-
ing sites in mitochondria (Quinlan et al., 2014). This study also
indicates that Odh and Pdh rather than the ETC Complexes may
serve as the central hub for ROS signaling from mitochondria
to the rest of the cell and thus may be an important pharma-
cological target for treatment of various diseases. For instance,
recent work published by Stuart et al. showed that lipoic acid
analog CPI-613 selectively kills cancer cells by amplifying ROS
production from the E3 subunit of Odh (Stuart et al., 2014). Thus,
Odh and Pdh need to be seriously considered as major contribu-
tors to mitochondrial O2•−/H2O2 genesis for ROS signaling and
mitochondrial dysfunction.
MITOCHONDRIAL TRANSPORT OF GLUTATHIONE AND ROS
DEGRADATION
Glutathione concentrations in the mitochondrial matrix are
equivalent to that found in the cytosol (Ribas et al., 2014).
Typically, glutathione within the mitochondria is maintained at
a high level; between 5 and 10mM, and comprises ∼10–15% of
the total cellular glutathione in the liver (Jocelyn and Kamminga,
1974) and ∼30% in the kidney (Schnellmann, 1991). Since the
production of glutathione occurs exclusively in the cytosol and
mitochondria lack the enzymes of glutathione synthesis and thus
all mitochondrial glutathione must be imported. Potential candi-
dates for glutathione importers include the 2-oxoglutarate carrier
(OGC) and the dicarboxylate carrier (DIC) in the liver and kid-
ney and the tricarboxylate carrier (TTC) in the brain (Mari et al.,
2013). Interestingly, a role for UCP2 in the transport of mito-
chondrial glutathione has been reported in neurons (de Bilbao
et al., 2004). This study suggests that the transport of protons back
into the matrix by UCP2 may favor the movement of glutathione.
Mitochondria contain a myriad of antioxidant defense
enzymes and low molecular weight molecules that degrade
both O2•− and H2O2 with exquisite efficiency (Mailloux et al.,
2013a). The antioxidant defense system in mitochondria has been
reviewed extensively (Murphy, 2012b; Mailloux et al., 2013a).
Of importance for our purposes in here is that mitochondrial
glutathione plays a number of roles as an antioxidant includ-
ing the direct sequestration of H2O2, detoxification of lipid
hydroperoxides, and S-glutathionylation of proteins to protect
from oxidative damage. Importantly, GSH itself does not sponta-
neously sequester hydroperoxides since the reaction kinetics are
far too slow (30 M−1 s−1) (Berndt et al., 2014a). Rather, the
capacity of glutathione to detoxify H2O2 and lipid hydroperox-
ides or participate in covalent modification of protein cysteine
thiols depends on various enzymes that specifically bind glu-
tathione to catalyze redox reactions (Flohe, 2013; Berndt et al.,
2014a). Indeed, H2O2 and lipid hydroperoxide detoxification are
enzymatically-mediated by glutathione peroxidase (Gpx) 1 and
Gpx4. Gpx1 is the matrix soluble isoform while Gpx4 is bound
to the MIM (Mailloux et al., 2013a). In addition, Gpx1 pref-
erentially scavenges H2O2 and Gpx4 is mostly involved in the
elimination of lipid hydroperoxides. The scavenging of H2O2 via
the glutathione system requires two GSH molecules. Interaction
with H2O2 generates GSSG which is then reduced back to GSH by
NADPH and glutathione reductase (Flohe, 2013). Mitochondria
contain a number of NADPH generating enzymes which are
required to funnel additional reductive power to antioxidant
systems (Mailloux et al., 2013a).
S-GLUTATHIONYLATION REACTIONS IN MITOCHONDRIA
NON-ENZYMATIC PROTEIN S-GLUTATHIONYLATION
Protein cysteine SH groups can be subjected to a range of dif-
ferent redox modifications which are dependent on H2O2 levels,
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GSSG concentration, presence of H2S, availability of nitric oxide,
proximity of neighboring SH groups (for inter or intramolecular
disulfide formation), proximity of amides or sulfenic acid
residues (Goubern et al., 2007; Grek et al., 2013; Mailloux et al.,
2013b). Since we are focusing on S-glutathionylation reactions we
will not discuss the other protein cysteine SH redox modifica-
tions. However, we encourage the reader to consult the following
comprehensive reviews for detailed information on all other
known redox modifications (Murphy, 2012b; Grek et al., 2013;
Mailloux et al., 2013b). Protein S-glutathionylation can pro-
ceed either non-enzymatically or enzymatically. Non-enzymatic
S-glutathionylation reactions are classically viewed as occur-
ring when the 2GSH/GSSG ratio is ∼1, e.g., during oxidative
stress (Ziegler, 1985; Gallogly and Mieyal, 2007). However, it
has now been established that glutathione S-transferases catalyze
protein S-glutathionylation (Klaus et al., 2013). Non-enzymatic
PSSG formation can proceed as follows; (1) simple disulfide
exchange with GSSG granted that GSSG is sufficiently con-
centrated (2GSH/GSSG is ∼1), (2) S− is oxidized by H2O2
generating a sulfenic acid (SOH) which, due to its very low
pKa, can ionize and rapidly react with reduced glutathione
(GSH), and (3) S− forms a thiyl radical which then inter-
acts with GSH forming a thiyl radical glutathionyl interme-
diate which then interacts with O2 to form PSSG (Mailloux
et al., 2013a). Spontaneous S-glutathionylation can play impor-
tant roles such as protecting SH groups from irreversible oxi-
dation by H2O2 during oxidative stress (Nulton-Persson et al.,
2003). However, it has also been suggested that spontaneous
PSSG formation could also occur under normal conditions.
This would be dependent on the state of redox microenvi-
ronments. For example due to its extreme folding, the mito-
chondrial MIM creates mitochondrial sub-compartments in the
matrix and intermembrane space which can generate very dis-
tinct microenvironments with different redox signatures (Drose
et al., 2014). This would mean that mitochondria could cre-
ate various redox gradients under normal conditions which
would render proteins more amenable toward spontaneous S-
glutathionylation under normal conditions. The capacity of a
protein to undergo spontaneous S-glutathionylation would also
depend on its reactivity toward either GSSG or H2O2. It has
been reported that the Kox for a typical protein is ∼1 (when
2GSH/GSSG is ∼1) (Gilbert, 1995). However, some proteins
like c-Jun have a Kox of ∼13 and therefore 50% of c-Jun is S-
glutathionylated when 2GSH/GSSG is ∼13 (Klatt et al., 1999).
This could also be the case for some mitochondrial proteins
like Complex I and Odh which seem to be quite sensitive to
S-glutathionylation (Beer et al., 2004; Applegate et al., 2008).
In addition, a recent report has established that proteins and
enzymes have S-glutathionylation motifs which are rich in pos-
itively charged amino acids surrounding a modifiable cysteine
(Chen et al., 2014). Thus, although non-enzymatic or sponta-
neous S-glutathionylation may occur in response to oxidative
stress, this type of S-glutathionylation could also proceed in nor-
mal cells considering that the 2GSH/GSSG pool is dynamic and
that redox gradients can be created in various mitochondrial
compartments and subcompartments.
ENZYMATICALLY DRIVEN PROTEIN S-GLUTATHIONYLATION
REACTIONS
It has long been known that cytosolic thiol oxidoreduc-
tase glutaredoxin-1 (Grx1) catalyzes the deglutathionylation of
cytosolic proteins (Mannervik and Axelsson, 1980). In vitro Grx1
is also able to deglutathionylate purified mitochondrial matrix
proteins or enzymes in permeabilized mitochondria (Gallogly
et al., 2009; Stroher and Millar, 2012). Grx1 is a small heat-
stable enzyme and amember of the thioredoxin (Trx) superfamily
(Stroher andMillar, 2012). Grx1 harbors has a thioredoxin fold (4
β-sheets surrounded by α-helices) and contains a catalytic CXXC
motif located on the loop region at the end of the first α-helix
(Stroher and Millar, 2012). Grx1 catalyzes deglutathionylation of
target proteins by nucleophilic displacement which has been very
well characterized and reviewed extensively elsewhere (Holmgren,
1988; Gallogly et al., 2009). The rate of Grx1-mediated protein
deglutathionylation varies substantially between 1.75 × 105 and
4.0 × 102 M−1s−1 which is heavily dictated by the pKa of the
target thiol (e.g., the lower the pKa the faster the rate) and acces-
sibility (Jensen et al., 2014). The mitochondrial matrix contains
a Grx1 isozyme, Grx2 (Gladyshev et al., 2001; Lundberg et al.,
2001). Grx2 was identified a little over a decade ago, shares ∼34%
sequence identity with Grx1, and is highly concentrated (∼1μM
in comparison to Grx1 which is ∼0.1μM) in mitochondria
(Gallogly et al., 2008). Grx2 is also a dithiol oxidoreductase
and uses a similar catalytic mechanism to Grx1 for the deglu-
tathionylation of target proteins. An exception here is that the
Grx2-SSG intermediate can also be reduced by thioredoxin reduc-
tase (TrxR) in an NADPH-dependent fashion (Johansson et al.,
2004). It has also been reported that Grx2 can reduce mitochon-
drial Trx2 (Zhang et al., 2014). These observations are intriguing
since Trx reductase (TrxR) is the only enzyme known to reduce
Trx2. TrxR is also very sensitive to deactivation by electrophiles
like 4-hydroxy-2-nonenal (Zhang et al., 2014). Thus, Grx2 is
able to maintain Trx2 activity when TrxR is deactivated under
oxidative stress. Notably, Grx2 is not sensitive to deactivation by
electrophilic or oxidative stress. Grx2 has also been reported to
catalyze the reduction of intra and intermolecular thiol disulfide
bridges. This is intriguing considering that Grx2 deglutathiony-
lase activity operates via a monothiol mechanism which requires
only the N-terminal active site cysteine. Reduction of disulfides
requires both N-terminal and C-terminal cysteines which has
been reviewed in Lillig and Berndt (2013).
Grx2 is modulated by the assembly of 2Fe-2S cluster which
maintains Grx2 as an inactive dimer (Lillig et al., 2005).
Disassembly of the 2Fe-2S cluster leads to the release of two acti-
vate Grx2 monomers which can then deglutathionylate protein
targets in mitochondria. It has been suggested that the 2Fe-2S
cluster serves as a sensor for oxidative stress and fluctuations in
redox environment in mitochondria (Lillig et al., 2005). A burst
in ROS production in mitochondria, most likely O−•2 , would
lead to oxidation of the glutathione pool and the subsequent S-
glutathionylation of various proteins. Active Grx2 would then
be required to restore the S-glutathionylated proteome in mito-
chondria. Grx2 is then subsequently deactivated by 2Fe-2S cluster
reassembly (Qi and Cowan, 2011). In a recent study, Gao et al.
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were able to activate holo-Grx2 using a xanthine/xanthine oxi-
dase system indicating O−•2 may be responsible for 2Fe-2S cluster
disassembly (Gao et al., 2013). It is important to point out that in
the same study the authors failed to activate Grx2 inmitochondria
incubated in 20mM glutamate and 7.5μM rotenone (Gao et al.,
2013). However, it should be noted that O−•2 production was not
measured and other potential substrates known to generate high
amounts of O−•2 , like succinate in conjunction with antimycin A,
were never tested. Grx1 and Grx2 also have glutathionylase activ-
ity. For Grx1 this is thought to occur via the stabilization of a
glutathionyl radical which then ultimately results in its transfer
to a target protein (Gallogly et al., 2008). A similar mechanism
may exist for Grx2 however; Grx2 glutathionylase activity seems
to be activated by the redox state of the 2GSH/GSSG pair. A more
oxidized glutathione pool activates the glutathionylase activity of
Grx2 whereas a reduced pool has the opposite effect (Beer et al.,
2004). This has been effectively demonstrated for Complex I in
bovine and mouse heart mitochondria (Beer et al., 2004) How
an oxidized glutathione pool activates the glutathionylase activ-
ity of Grx2 remains unclear however; our group has suggested a
potential mechanism in a previous publication (Mailloux et al.,
2013b). Fe-S cluster coordination by Grx2 also requires 2GSH
molecules which are required to stabilize the Grx2 dimer—2Fe2S
cluster assembly (Berndt et al., 2007; Lillig and Berndt, 2013). It
is possible that oxidation of the GSH pool also results in 2Fe-2S
cluster disassembly and activation of Grx2 via an initial liberation
of GSH from the complex.
GRX2 IN EMBRYONIC DEVELOPMENT, HEALTH, AND DISEASE
Cellular redox balance is essential for modulating protein activ-
ities in mammalian cells. To this end the thiol oxidoreductase
activity of Grx2 has been shown to be indispensable for proper
mitochondrial function in various tissues. Selective overexpres-
sion of Grx2 in mouse heart protects from doxorubicin induced
cardiac injury (Diotte et al., 2009). Grx2 overexpression also pro-
tects from ischemia-reperfusion injury, apoptosis, and reduces
infarct formation in heart tissue (Gallogly et al., 2010; Wu et al.,
2010). Likewise Grx2 knockout induces left ventricular hypertro-
phy and localized fibrosis in mice (Mailloux et al., 2014). Grx2
overexpression has also been shown to curtail MPP+ toxicity
in neuroblastoma cells and is upregulated rapidly in midbrain
and striatum following MPTP treatment (Karunakaran et al.,
2007). A report has also suggested that gene therapy, specifically
with thioredoxin superfamily genes (e.g., Grx2), may serve as a
novel avenue for treatment of heart disease (Ahsan et al., 2009).
Through a series of publications Brautigam et al. and Berndt et al.
were able to show that Grx2 plays a critical role in embryonic
development. Specifically, using a zebrafish model and various
types of cultured cells, it was shown that Grx2 plays a pivotal role
in brain development (Brautigam et al., 2011), regulates vascu-
larization via Sirt1 S-glutathionylation (Brautigam et al., 2013),
and heart development by regulating neural crest cell migra-
tion and survival (Berndt et al., 2014b). Loss of Grx2 curtails
these development pathways which severely hampers embryonic
development. Collectively, these studies highlight the important
function of redox signaling, mediated by Grx2, in embryonic
development, cell function, and tissue health.
MITOCHONDRIA ARE IMPORTANT SITES FOR REGULATION
BY S-GLUTATHIONYLATION
S-glutathionylation is required to modulate cytoskeletal dynam-
ics, cell motility, cell division, ion transport, calcium home-
ostasis, gene expression, epigenetics, glycolysis, energy sensing
through AMP kinase, bicarbonate metabolism, and apoptosis
(Cooper et al., 2011; Pimentel et al., 2012). Deregulation of
reversible S-glutathionylation also has strong implications for
health and disease. Like many other pathological conditions that
involve deregulated covalent modifications (e.g., phosphoryla-
tion or acetylation), altered S-glutathionylation patterns have
been linked to various disease states including obesity, diabetes
mellitus, cardiovascular disease, inflammation, cancer, and aging
(Cooper et al., 2011; Picklo et al., 2013; Sanchez-Gomez et al.,
2013; Seo and Lee, 2014). Emerging evidence now indicates that
S-glutathionylation reactions also play a central role in mod-
ulating mitochondrial function in various organs and tissues.
The mitochondrial matrix favors S-glutathionylation reactions
(Murphy, 2012b). A review of the literature reveals that a number
of mitochondrial proteins involved in a diverse array of pro-
cesses can be S-glutathionylated (reviewed by Mailloux et al.,
2013a,b; Drose et al., 2014). Most of these proteins seem to be S-
glutathionylated under oxidative stress and it remains unknown
if S-glutathionylation is required to regulate their physiological
function(s) (Mailloux et al., 2013a). From the list of 15 proteins
involved in metabolism, ROS homeostasis, and apoptosis, only a
handful seem to be (1) regulated by reversible S-glutathionylation
and (2) display altered S-glutathionylation patterns in various
pathologies (Mailloux et al., 2013a). In addition, out of this same
list of proteins Complex I of the ETC has been identified as the
only bona fide target for Grx2 action (Mailloux et al., 2013a).
Recent reports have also linked Grx2 function to the regulation
of UCP3 (Mailloux et al., 2013c). However, knockout of Grx2 in
mice results in S-glutathionylation of a number of proteins at var-
iousmolecular weights in liver and heart mitochondria suggesting
that Grx2 may have a multitude of targets (Mailloux et al., 2013c,
2014).
ACONITASE (Acn)
Acn is the second enzyme of the Krebs cycle and catalyzes the
isomerization of citrate to isocitrate through a cis-aconitate inter-
mediate. Catalysis is dependent on a cubane [4Fe-4S]2+ cluster
which is required to facilitate the elimination of the hydroxyl
group from C3 position of citrate (Gardner, 1997). Specifically
the solvent exposed Fea group in the cluster is required for
coordination of the OH group on the C3 prompting its elim-
ination and the genesis of a cis-aconitate intermediate (Lauble
and Stout, 1995). The solvent exposed Fe-S cluster in Acn also
makes it highly amenable for deactivation by O2•−. Inactivation
is caused by oxidation of the cluster followed by release of
Fea (which is required to coordinate OH on C3 position of
citrate) and cluster disassembly (Gardner, 1997). Second-order
rate constants for this reaction are ∼107 M−1s−1 (Flint et al.,
1993). However, it should be noted that [4Fe-4S]2+ clusters
can also be disassembled by ONOO− (Kennedy et al., 1997).
Nevertheless, Acn deactivation during oxidative stress is asso-
ciated with various diseases including obesity, cardiovascular
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diseases, and neurological disorders (Wlodek and Gonzales, 2003;
Goncalves et al., 2010).
Recent work has established that Acn is also a key site for
modulation by cysteine oxidation reactions (Han et al., 2005).
It has been demonstrated that cysteine residues in close prox-
imity to the citrate binding site, specifically Cys126 and Cys385,
can form sulfenic (SOH) and sulfinic (SO2H) acids in the pres-
ence of H2O2 (Han et al., 2005). These cysteine residues are
also amenable to S-glutathionylation which lowers Acn activity
most likely through blocking the active site (Han et al., 2005).
S-glutathionylation is also inversely proportional to the concen-
tration of citrate (Han et al., 2005). Thus, Acn S-glutathionylation
is dependent on whether or not citrate is available to occupy the
active site. It has long been known that citrate or analogs like tri-
carballylic acid are required to bind and stabilize the [4Fe-4S]2+
in Acn during isolation procedures. It is entirely possible that S-
glutathionylation of active site cysteine residues may protect Acn
from irreversible deactivation in various tissues by preventing
Fe-S disassembly by O2•− and ONOO− when citrate (or cis-
aconitate and isocitrate) is unavailable to occupy the active site.
In addition, deregulation of S-glutathionylation of Acn may con-
tribute to the pathogenesis of various disorders including obesity
and neurological diseases. As noted above Acn is a major target
for deactivation by oxidative stress in various pathologies. Thus,
disruption of Acn S-glutathionylation could amplify the probabil-
ity of deactivation and may contribute to development of various
diseases.
Pdh, Odh, AND Bckdh
Pdh and Odh are multienzyme complexes that utilize vari-
ous cofactors and coenzymes including thiamine pyrophosphate
(TPP, E1), lipoic acid (E2), coenzyme A (CoASH, E2substrate),
FAD (E3), and NAD (E3 substrate) to catalyze the conversion of
pyruvate (Pdh) or 2-oxoglutarate into acetyl-CoA or succinyl-
CoA, respectively (McLain et al., 2011). The overall catalytic
cycle for both enzymes begins with the formation of a covalent
bond between TPP and substrate and the elimination of CO2
(Figure 2). The carbanionic substrate is then transferred to lipoic
acid which then reacts with CoASH to generate either acetyl-
CoA or succinyl-CoA. The reduced dihydrolipoate residue is then
oxidized by FAD and the liberated electrons are passed to NAD
yielding NADH. Pdh and Odh serve as major entry points into
the Krebs cycle and are thus important control points for the flux
of metabolites into and out of the Krebs cycle (Humphries and
Szweda, 1998).
Pdh and Odh are highly sensitive to redox regulation. In
particular, the lipoate residue in the E2 subunit is sensitive to
oxidative deactivation by H2O2. This effectively limits Pdh and
Odh activity prompting the accumulation of pyruvate or 2-
oxoglutarate which can quench ROS albeit with very slow kinetics
(Mailloux et al., 2007, 2013a). This also limits NADH production
which aids in preventing the further genesis of O2•−/H2O2 by
either enzyme or the respiratory chain. If H2O2 is too concen-
trated the E2 subunit can be irreversibly deactivated by overoxi-
dation. Low μM amounts of H2O2 can rapidly oxidize the thiol
residues on lipoic acid to SOH and deactivate Odh (Figure 2)
(Applegate et al., 2008). SOH can then undergo further oxidation
by H2O2 generating sulfinic (SO2H) and sulfonic acid (SO3H)
which irreversibly deactivates the enzyme complex. This could
be detrimental since it would disable the flux of metabolites
through the Krebs cycle. Irreversible deactivation is prevented
by S-glutathionylation of SOH groups. In a series of publica-
tions, Sweda et al. firmly established that the vicinal lipoate thiols
in Odh can be rapidly oxidized by μM amounts of H2O2 fol-
lowed by rapid S-glutathionylation of SOH groups in rat heart
mitochondria (Nulton-Persson et al., 2003; Applegate et al., 2008;
McLain et al., 2013). In addition, the same group showed that
S-glutathionylation can be reversed by exogenous Grx1 and that
calcium enhances the probably of S-glutathionylation (Figure 2)
(Applegate et al., 2008). These seminal findings illustrate that Odh
is a major focal point for rapid regulation by fluctuations in redox
environment (Figure 2). Indeed, a burst in H2O2 production in
mitochondria may be required to feedback and deactivate Odh
and possibly Pdh to curtail further H2O2 production by either
Odh and Pdh or the respiratory complexes (Figure 2) (Young
et al., 2000; Green et al., 2003). S-glutathionylation prevents fur-
ther deactivation and ensures that Odh can be rapidly reactivated
possibly by Grx2.
The vicinal lipoate thiols on the E2 subunit of Odh can be sub-
jected to a range of oxidative modifications. Odh is deactivated
by H2O2-induced oxidative stress in nerve terminals which has
strong implications for Parkinson’s disease (Tretter and Adam-
Vizi, 1999; Kumar et al., 2003). Thiolates and SOH groups can
also be targeted for alkylation. For instance, lipid damage fol-
lowing oxidative stress generates 4-hydroxy-2-nonenal (HNE), a
highly reactive electrophile that can rapidly conjugate to reac-
tive thiols and SOH groups (Forman et al., 2008). Odh is a
target for deactivation by HNE (Humphries and Szweda, 1998).
Treatment of cardiac mitochondria with HNE results in a rapid
decrease in energy metabolism and deactivation of Odh and for-
mation of HNE adducts is a hallmark of cardiac and neurological
diseases (Humphries and Szweda, 1998). S-glutathionylation of
Odh and possibly Pdh and Bckdh prevents HNE adduct forma-
tion and/or overoxidation of lipoate groups by blocking vicinal
thiols. Disabling S-glutathionylation may have strong implica-
tions for development of various neurological and cardiovascular
diseases. A hallmark for heart and neurological disease is the
depletion of mitochondrial glutathione pools which coincides
with diminished mitochondrial respiration and metabolism (Jha
et al., 2000; Mari et al., 2009). Depletion of mitochondrial glu-
tathione would inevitably result in the loss of a key protective
mechanism required to retain Odh and possibly Pdh and Bckdh
activity. In fact, therapies for treating various neurological dis-
orders are aimed at preserving mitochondrial glutathione levels
(Pastore et al., 2013; Smeyne and Smeyne, 2013). Thus, Odh,
Pdh, and Bckdh serve as important regulatory hubs for reversible
S-glutathionylation reactions which if disabled can lead to the
development of various disorders.
COMPLEX I; NADH:UBIQUINONE OXIDOREDUCTASE
Complex I catalyzes the two-electron oxidation of NADH and
reduction of ubiquinone to ubiquinol which is coupled to the
translocation of ∼4 H+ to the P-side of the MIM (Verkhovskaya
and Bloch, 2013). Overall Complex I has 46 subunits and forms
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FIGURE 2 | Odh serves as an important sensor for mitochondrial
O2•−/H2O2 levels. (A) Odh-mediated conversion of 2-oxoglutarate into
succinyl-CoA depends on electron transfer reaction to NAD generating
NADH. Movement of electrons from 2-oxoglutarate is facilitated by lipoic acid
and FAD in the E2and E3 subunits. Red circles: represent the major site for
O2•−/H2O2 by Odh. (B) Regulation of Odh by reversible S-glutathionylation
and how this mechanism could hypothetically modulate the emission of
O2•−/H2O2from this enzyme complex. A small increase in mitochondrial
H2O2 oxidizes vicinal thiols (SH) in Odh to sulfenic acid (SOH) which
deactivates Odh. To avoid irreversible oxidation, SOH is conjugated to
glutathione which can be subsequently removed, possibly by Grx2, to
reactivate Odh.
an L-shaped protein complex composed of a hydrophilic arm that
protrudes into the matrix and a membrane arm that is embedded
in theMIM (Mimaki et al., 2012). The hydrophilic arm consists of
twomodules, the N-module which contains the NADH oxidation
site and FMN and the Q-module which harbors the ubiquinone
binding site (Mimaki et al., 2012). In between the NADH oxi-
dation and ubiquinone binding sites are 8–9 Fe-S clusters which
link hydride transfer from NADH to FMN in the N-module
to the two electron reduction of ubiquinone in the Q-module
(Verkhovskaya and Bloch, 2013). Note that the ubiquinone bind-
ing site is thought to sit at the interface between the Q-module
and P-module (proton pumping membrane arm) (Mimaki et al.,
2012). Complex I activity is heavily regulated by allosteric and
covalent mechanisms which converge on both the N-module and
Q-module. TheN-module consists of threemain nuclear encoded
proteins Ndufv1, Ndufv2, and Ndufs1 (Mimaki et al., 2012). The
Q-module consists mainly of nuclear encoded proteins Ndufs3,
Ndufs8, Ndufs2, and Ndufs7 (Mimaki et al., 2012). The P-module
is composed of highly hydrophobic proteins encoded by the
mitochondrial genome. Several subunits in the N-module have
been identified as key sites for regulation by S-glutathionylation.
Specifically Ndusf1 (∼75 kDa) and Ndufv1 (∼51 kDa) have been
identified as major S-glutathionylation targets (Hurd et al., 2008;
Chen et al., 2010; Mailloux et al., 2014). S-glutathionylation of
either protein results in a decrease in Complex I activity. Complex
I has been shown to be modulated by S-glutathionylation in
a number of tissues including cardiac, liver, and lens epithelia
with Ndusf1 and Ndufv1 serving as chief targets (Hurd et al.,
2008; Passarelli et al., 2010; Wu et al., 2011; Mailloux et al.,
2013c). The accessory subunit Ndufa11, which plays a role in
Complex I assembly and stability, has also been shown to be
S-glutathionylated and displays altered S-glutathionylation pat-
terns in isolated mouse hearts subjected to ischemia-reperfusion
(Kumar et al., 2013).
Some of the most intriguing results concerning
S-glutathionylation of Complex I in health and disease come
from Ndusf1. Ndusf1 can be S-glutathionylated on Cys531 and
Cys704 in bovine heart mitochondria which lowers its activity
(Hurd et al., 2008). Cys531 and Cys704 are close to the NADH
binding site and thus it is probable that S-glutathionylation
induces a conformational change in the N-module which dimin-
ishes NADH oxidation (Hurd et al., 2008). The most intriguing
aspect of Ndusf1 is that it is reversibly S-glutathionylated by
Grx2 (Beer et al., 2004; Mailloux et al., 2014). It has now been
shown in bovine and mouse heart mitochondria that Grx2
can deglutathionylate Complex I. Moreover, Beer et al. was
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able to show that Grx2 can also S-glutathionylate Complex
I (Beer et al., 2004). The capacity of Grx2 to catalyze either
deglutathionylation or S-glutathionylation depends on the redox
state of the 2GSH/GSSG pair. A more oxidized ratio activates
Grx2 glutathionylase activity whereas a more reduced ratio has
the opposite effect. In addition Mailloux et al. was able to show
that Grx2 knockout (Grx2−/−) inhibits Complex I activity by
S-glutathionylation of Ndusf1 which can be reversed by (1)
restoring the redox environment through GSH supplementation
and (2) addition of exogenous Grx1 (Mailloux et al., 2014).
As described above Grx2 is required to reverse
S-glutathionylation of Complex I. In addition, Complex I
can be easily S-glutathionylation by an increase in GSSG (Beer
et al., 2004; Passarelli et al., 2010; Mailloux et al., 2014). In a
recent study, Mailloux et al. provided evidence that loss of Grx2
function results in development of left ventricular hypertrophy
and localized fibrosis which is associated with increased reliance
on glycolysis to meet energy demands (Mailloux et al., 2014). In
addition, Grx2−/− mice also develop hypertension which often
goes hand in hand with cardiac hypertrophy (Mailloux et al.,
2014). This was associated with increased O2•− production and
inhibition of Complex I activity in cardiac tissue and a ∼50%
decrease in mitochondrial ATP production (Mailloux et al.,
2014). The massive decline in mitochondrial ATP production is
highly significant for cardiac tissue considering the contracting
heart can turnover ∼30 kg of ATP a day and relies on mito-
chondria to fulfill ∼90% of its energy demands (Rosca and
Hoppel, 2010). The decrease in mitochondrial ATP production
was associated with decreased Complex I activity which could
be easily reversed by restoration of reductive environment in
mitochondria with DTT or GSH (Mailloux et al., 2014). The
observation that restoration of the redox environment recovers
ATP production and Complex I activity indicates the possibility
that pharmacological agents can be designed and targeted to
mitochondria to ameliorate deregulated S-glutathionylation
reactions. These results are consistent with other studies where
overexpression of Grx2 protects mouse heart mitochondria
from doxorubicin-induced cardiac injury by maintaining State
3 respiration (Diotte et al., 2009). Further, Grx2 overexpression
protects from apoptosis and prevents cytochrome C release by
maintaining Complex I activity (Enoksson et al., 2005). Thus,
S-glutathionylation reactions play a central role in modulating
mitochondrial ATP in cardiac tissue, most likely in response to
changing energy demands and ROS levels, and deregulation of
these reactions can lead to development of heart disease.
Another intriguing aspect for modulation of Complex I activ-
ity through thiol modification is the active/deactive (A/D) tran-
sition. Complex I can cycle between A and D-forms which is
dependent onNADH and ubiquinone (Grivennikova et al., 2001).
What is interesting here is that transition to D-form results in
exposure of a conserved cysteine residue which can be read-
ily modified by thiol modifying reagents N-ethylmaleimide or
iodoacetamide (Babot et al., 2014). It has been established that
Cys39 on Complex I subunit ND3, which forms part of the
P-module, becomes exposed upon A to D transition and can
then be modified by alkylating agents. Notably Cys39 of ND3
makes contact with the solvent inaccessible ubiquinone binding
site which sits at the interface between the hydrophilic and
hydrophobic arm of Complex I (Babot et al., 2014). Thus, dur-
ing two-electron oxidation of NADH the ubiquinone binding site
is closed ensuring electron transfer and reduction of ubiquinone
can proceed. When substrate abundance is low, ND3 undergoes
a conformational change exposing Cys39 making it amenable for
modification resulting in Complex I deactivation. Of note Cys39
of ND3 subunit can undergo S-nitrosylation which was shown
to protect cardiac tissue from ischaemia-reperfusion and reduce
myocardial infarct size (Chouchani et al., 2013). Dröse et al. pro-
posed that Cys39 on ND3 may also serve as an important site
for regulation of Complex I activity by redox modifications like
S-glutathionylation (Drose et al., 2014).
Studies have found that Complex I S-glutathionylation can
increase and decrease O2•− formation. Hurd et al. found that S-
glutathionylation of Ndusf1 diminishes O2•− formation by the
Complex which is most likely due to blocking hydride transfer
from NADH to FMN and prevention of the formation of FMN
semiradicals during 1 electron transfer to Fe-S in the Complex
(Hurd et al., 2008). However, the same group and others have
shown S-glutathionylation of Complex I can increase O2•− pro-
duction (Taylor et al., 2003; Mailloux et al., 2014). There are
two reasonable explanations for this discrepancy. The first is
that S-glutathionylation may initially prevent O2•− production
by Complex I but chronic/prolonged S-glutathionylation may
have the opposite effect (e.g., increase O2•− production). This
is especially relevant for cardiac tissue considering that fatty acid
oxidation (FAO) accounts for ∼60–90% of the ATP produced by
mitochondria. Prolonged inactivation of Complex I can amplify
FAO-mediated O2•− production from a number of sites in the
ETC and from Odh and Pdh due to an increase in NADH/NAD
(Figure 3). In terms of short term regulation S-glutathionylation
may diminish O2•− production following a burst in O2•−/H2O2
production by mitochondria (Figure 3). This leads to an increase
in GSSG and S-glutathionylation of Complex I decreasing its
activity and O2•− production. Grx2 is activated by the burst
of O2•− production which subsequently deglutathionylates and
reactivates Complex I (Figure 3). This hypothetical mechanism
is anticipated to be very rapid mode of regulation required to
adjust O2•− production and ROS emission by mitochondria in
response changes in redox environment (Figure 3). It also most
likely plays a central role in controlling ROS signaling from
mitochondria to the rest of the cell. Depending on the energy
demands of cardiac tissue this mechanism may also be required
to control ATP output. However, disabling Grx2 or oxidative
stress can induce prolonged Complex I S-glutathionylation which
could eventually drastically amplify mitochondrial ROS emis-
sion (Figure 3). The second explanation for this discrepancy is
Complex I harbors multiple S-glutathionylation sites which may
affect whether or not O2•− production is increased or decreased
(Figure 3). Indeed, both Ndufs1 and Nduv1 form part of the
NADH binding site and S-glutathionylation of either protein or
both may actively prevent the two-electron reduction of FMN
by NADH—however, prolonged S-glutathionylation may result
in electron backflow from a reduced quinone pool and produc-
tion of O2•− by FMN (Figure 3). Ndufa11 S-glutathionylation
may have a similar effect regulating Complex I assembly thereby
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FIGURE 3 | Complex I harbors multiple S-glutathionylation sites which
may serve as a “cysteine code” required to modulate its activity under
various conditions. (A) Representative diagram illustrating the basic
structure of Complex I and the location of the various modules, prosthetic
groups, and proton pumping domains. Subunits that can be
S-glutathionylated are highlighted. Hexagon; FMN, circles; Fe-S clusters,
square; ubiquinone binding site. (B) Complex I cysteine code. Hypothetical
schematic depicting the different possible S-glutathionylation states that can
be adopted by Complex I under physiological (regulatory) and pathological
conditions. Note that S-glutathionylation of the different subunits in different
combinations ultimately lowers Complex I activity but duration and location of
S-glutathionylation can have variable effects on O2•− emission. “a”
corresponds to Ndufs1 or Ndufv1 and “b” corresponds to ND3. Note that
accessory protein Ndufa11 has been excluded for clarity but may also be
differentially S-glutathionylated in response to various physiological and
pathological stimuli.
modulating respiratory complex content in mitochondria which
would affect ROS production. In addition, the observation that
Ndufa11 is S-glutathionylated would indicate that the mito-
chondrial redox environment plays an intricate role in respira-
tory complex assembly and possibly even respirasome assembly.
Concerning ND3, although it has a modifiable cysteine residue
it remains unknown if it is S-glutathionylated. However, it is
tempting to speculate that it is S-glutathionylated and that it
also influences O2•− production by Complex I. In this par-
ticular scenario ND3 S-glutathionylation and prolonged deac-
tivation of Complex I may actually increase O2•− formation
(Figure 3). S-glutathionylation of ND3 may prevent ubiquinone
binding prompting a build-up in FMN radical and a sub-
sequent increase in O2•− formation (Figure 3). It would be
important to decipher if S-glutathionylation of any of these pro-
teins, perhaps using Cys substitution models and knockouts,
enhances or diminishes mitochondrial O2•−production. Also
it would be important to determine the circumstances under
which each subunit is S-glutathionylated and if all subunits can
be S-glutathionylated simultaneously and the impact different
S-glutathionylation states has on Complex I function. Thus, it
remains unknown if all subunits (Ndufs1, Ndufv1, Ndufa11,
and ND3) can be S-glutathionylated simultaneously or if these
subunits are differentially S-glutathionylated under different
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conditions, either physiological (e.g., regulation) or under oxida-
tive stress/pathological conditions. As shown in Figure 3, we have
generated six different hypothetical models illustrating what may
ormay not happen when Complex I is S-glutathionylated on these
different subunits in different combinations and what may occur
under (1) regulatory and (2) pathological conditions. We propose
that Complex I actually harbors an S-glutathionylation cysteine
code that is required to fine tune cardiac metabolism in response
to various stimuli and that disruption of this signaling platform is
detrimental to heart physiology.
COMPLEX II; SUCCINATE DEHYDROGENASE
Succinate dehydrogenase [(Sdh) succinate-coenzyme Q reduc-
tase or succinate-ubiquinone oxidoreductase] is a multienzyme
complex bound to the inner membrane of the mitochondria and
many bacterial cells (Figure 4). It has multiple roles, participat-
ing in both the citric acid cycle as well as the ETC. Sdh catalyzes
the oxidation of succinate to fumarate, with the corresponding
reduction of ubiquinone to ubiquinol. Sdh is comprised of four
protein subunits (SdhA, SdhB, SdhC, and SdhD) and a heme cen-
ter. SdhA (a flavoprotein which converts FAD to FADH2) and
SdhB (containing three iron-sulfur clusters; [2Fe-2S], [4Fe-4S],
and [3Fe-4S]) are hydrophilic and occur within the mitochon-
drial matrix. SdhC and SdhD are hydrophobic and occur within
the inner leaflet of the MIM, binding a heme b560 molecule
in between them. The oxidation of succinate to fumarate, with
the corresponding reduction of FAD to FADH2 occurs in SdhA.
Electrons derived from FAD tunnel through the iron-sulfur clus-
ters of SdhB (from [2Fe-2S] to [4Fe-4S] to [3Fe-4S]) to a waiting
ubiquinone in the active site of SdhC. The heme prosthetic group
is suggested to be an electron sink, with electrons tunneling back-
and-forth between ubiquinone and heme b560. Thus, the heme
may prevent electrons escaping to molecular oxygen and forming
O2•−. Indeed, mounting evidence has suggested that Sdh can be
a significant source of ROS. Studies show that ROS production
by inhibition of Sdh occurs both indirectly and directly. In terms
of the former this occurs through inhibition of the ubiquinone
binding site (atpenin A5, TTFA) or the succinate binding site
(malonate) and the latter via autooxidation of flavin (Zhang et al.,
1998).
Removal of Sdh function in mice has been shown to be embry-
onic lethal (Piruat et al., 2004). Mutations in the SdhA subunit
can lead to Leigh syndrome, mitochondrial encephalopathy, and
optic atrophy (Jain-Ghai et al., 2013). Mutations in SdhB, SdhC
and SdhD subunits lead to tumorogenesis in chromaffin cells, as
well as in the head and neck regions, resulting in hereditary para-
ganglioma and hereditary pheochromocytoma (Bardella et al.,
2011; Hoekstra and Bayley, 2013). These mutations also lead to
increased O2•− production and decreased lifespan (Slane et al.,
2006). Mutations in SdhC, in particular, may lead to alteration
of the binding site for ubiquinone, causing a rerouting of the
electron flow from ubiquinone to molecular oxygen. Chronic
O2•− production, dismutated to H2O2, in these mutants results
in localized genomic instability and other phenotypic changes
related to the development of cancer and cellular aging. Whereas
tumors resulting from SdhB mutation tend to be malignant,
tumors resulting from SdhC and SdhD mutations tend to be
benign.
Several studies have conclusively shown that S-
glutathionylation is required to modulate Sdh and that
FIGURE 4 | Modulation of Sdh by S-glutathionylation. Representative
diagram illustrating electron flow from succinate to ubiquinone in Sdh
with subsequent production of fumarate. The S-glutathionylation of
Cys90 on SdhA subunit is required to maintain succinate oxidation
activity and diminish O2•− production. Deregulation of SdhA
S-glutathionylation results in diminished activity and increased
mitochondrial ROS production which is associated with ischemic
damage of cardiac tissue.
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perturbations of Sdh S-glutathionylation are associated with
ischemia-reperfusion injury in cardiac tissue (Chen et al.,
2007). Intriguingly Sdh is actually deglutathionylated following
ischemia-reperfusion injury which diminishes succinate oxida-
tion and enhances O2•− by Complex II (Figure 4) (Chen et al.,
2007). It would appear that in this case S-glutathionylation,
specifically of Cys90 on SdhA subunit, is required to main-
tain activity. It has been proposed that S-glutathionylation of
Sdh is actually required to protect the enzyme from oxidative
deactivation possibly via a mechanism similar to Odh. Indeed,
it was also shown that S-glutathionylation of Sdh is required
to protect the enzyme complex from oxidative deactivation.
Specifically this is Cys90 of the SdhA subunit has been shown to
be S-glutathionylated using purified SdhA and liquid chromatog-
raphy/tandem mass spectrometry. In vitro S-glutathionylation
of Sdh has been shown to protect the enzyme from thiyl radical
formation induced by O2•− (Chen et al., 2007) as well as against
peroxynitrite-mediated tyrosine nitration and impairment of the
enzyme’s protein-protein interaction with Complex III (Chen
et al., 2008). Such damaging tyrosine nitration of SdhA has been
found to occur in the post-ischemic myocardium (Chen et al.,
2007). Cys90 of SdhA is persistently glutathionylated and thus
continuous modification of this subunit is considered essential to
the optimal functioning of this enzyme.
COMPLEX V; F0F1 ATP SYNTHASE
ATP synthase is an enzyme that synthesizes the energy currency
of the cell, adenosine triphosphate (ATP) (Figure 5). Complex V
has a hydrophobic Fo portion present within the inner membrane
of the mitochondria and a hydrophilic F1 portion present within
the matrix of the mitochondria. The F0 portion of the enzyme
contains subunits A, B, and C while the F1 portion contains sub-
units alpha (α), beta (β), gamma (γ), delta (δ), and epsilon (ε).
The pmf across the inner mitochondrial membrane, generated by
the ETC, drives the passage of protons through the membrane
via the Fo region of ATP synthase. A ring of 8-15 C subunits
(depending upon the species), and the ε subunit, rotates as pro-
tons pass through themembrane. This ring of C subunits is tightly
attached to a central stalk, consisting of the γ subunits, which
rotates within the fixed α3β3 subunits of F1. Protons pass through
channels in the A subunit, which rests against the C subunit ring,
from the mitochondrial intermembrane space to the matrix as
the C subunit ring turns. F0 is also connected to F1 by a periph-
eral stalk comprised of two B subunits and one δ subunit. The
rotation of the γ subunit within the α3β3 subunits of F1 causes
conformational changes in the ADP + Pi binding site of the β
subunits, resulting in the conversion of ADP to ATP. After one
complete rotation of F1, ATP is released, allowing another ADP +
Pi to bind.
The generation of ROS by mitochondria is highly depen-
dent upon mitochondrial membrane potential (m) and
the amount of ROS produced can either trigger cellular pro-
liferation (low ROS) or apoptosis (high ROS) (Martinez-
Reyes and Cuezva, 2014). Inhibition of ATP synthase by 1,4-
benzodiazepine-derivative Bz-423 induces mROS production and
signals apoptosis. This is the result of an increase in m and
FIGURE 5 | Modulation of ATP synthase by S-glutathionylation.
Diagrammatic representation of the ATP synthase complex and how it
couples proton transport to the synthesis of ATP. S-glutathionylation of
α-subunit in the F1 portion of the complex is required to modulate ATP
synthesis and curtail the genesis of mitochondrial O2•− production.
However, prolonged S-glutathionylation is associated with chronic
decreases in mitochondrial ATP production and development of heart
disease.
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subsequent superoxide production from the mitochondrial ETC
(Martinez-Reyes and Cuezva, 2014). ATPase Inhibitory Factor 1
(IF1) is a low molecular weight (∼10 kDa) mitochondrial protein
which acts as a natural inhibitor of ATP synthase, but does not
interfere with its coupling activity (Cabezon et al., 2000). IF1 is
activated under low pH conditions (which occurs with a change
in m) and binds to the α, β, and γ subunits of ATP synthase.
Binding of IF1 inhibits the conformational changes required for
ATP binding to the αβ sites of F1 and thus it disrupts the catalytic
site of ATP synthase (Campanella et al., 2008). Inhibition of the
ATP synthase increasesmitochondrialmand increased super-
oxide production from the mitochondria, activating proliferation
and survival pathways within the nucleus of the cell and promot-
ing tumorigenesis and metastasis (Formentini et al., 2012). IF1
is highly overexpressed in tumor cells which also shifts the cell
toward a more glycolytic phenotype.
In the heart, the α subunit of ATP synthase is glutathiony-
lated during dyssynchronous heart failure (DHF) and this can
be induced by GSSG in a dose-dependent manner. Interestingly,
the extent to which the α subunit of ATP synthase is glutathiony-
lated is partially normalized in cardiac resynchronization therapy
(CRT), providing evidence that this effective treatment for heart
failure patients also has beneficial effects in terms of oxidative
post-translational modification of mitochondrial proteins (Wang
et al., 2011). The α subunit of ATP synthase provides a redox
switch for the enzyme’s function under normal conditions and
conditions of oxidative stress (Wang et al., 2011) (Figure 5).
Cys294 of the α subunit can be oxidized to Cys294-SOH with
superoxide exposure or Cys294-SNO with nitric oxide exposure
(with increasing oxidative stress). These modifications can be
further oxidized to form a disulfide bridge with either Cys294
of an adjacent α subunit, Cys103 of the γ subunit of ATP syn-
thase or glutathione (S-glutathionylation) (Wang et al., 2011). All
three disulfide bridges cause a substantial decrease in ATP syn-
thase activity, leading to mitochondrial dysfunction. Antioxidant
systems that reverse disulfide bond formation would enhance
ATP synthase function under these conditions. Reversible S-
glutathionylation of Cys294 of the α subunit of ATP synthase,
although initially detrimental to the enzymes activity, would pro-
tect it from the irreversible modification of sulfenic to sulfinic
to sulfonic acid formation. Other studies have shown that dif-
ferent Cys residues on the α subunit of ATP synthase to be
S-glutathionylated during oxidative stress (upon H2O2 exposure
of isolated brain mitochondria) (Garcia et al., 2010). A previous
study identified one of the amino acid residues glutathionylated
to be Cys163 (West et al., 2006).
CONCLUSION AND PERSPECTIVES
Mitochondria are masters of energy conservation. In mitochon-
dria, electron transfer potentials are coupled to the genesis of
transmembrane protonic forces, a form of Gibbs free energy that
can be readily utilized for the synthesis of ATP. It is through
the process of oxidative phosphorylation that mitochondria were
able to aid in the development of evolutionary complexity and
the inevitable “ascent of man” (Wallace, 2010). Electron trans-
fer processes in mitochondria can also lead to the production of
ROS. Once viewed as unfortunate waste products of respiration
it is now well known that ROS serve as an important means
for mitochondria to regulate its own functions or communicate
with the rest of the cell. However, mitochondria must strike a
delicate balance when using ROS as a signaling molecule since
over production can induce cell damage and death. Indeed, mito-
chondrial dysfunction which is typically characterized by an ATP
production deficiency and/or over production of ROS can lead
to cell death and development of disease. In the present arti-
cle, we discussed emerging evidence and hypotheses around the
role of S-glutathionylation reactions in the control of mitochon-
drial metabolism and function in response to fluctuations in
redox environment. In addition, we provided a framework for
how disruption of S-glutathionylation signaling cascades can lead
to mitochondrial dysfunction and development of disease. S-
glutathionylation reactions, mediated by Grx2, play a central role
in regulating mitochondrial ATP production and ROS emission
in response to local and robust changes in redox environment, in
particular fluctuations in H2O2 and 2GSH/GSSG. Although only
a handful of Grx2 targets have been identified there are a number
of mitochondrial proteins, which fulfill a multitude of functions
that are known to undergo S-glutathionylation. It is important
to ascertain if these mitochondrial proteins can also be targeted
by Grx2 and the circumstances under which these proteins are
reversibly S-glutathionylated in response to redox environment
fluctuations.
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